August 2011 Br J Cardiol 2011;18(Suppl 2):s1-s15
Paul Kalra
Correction of anaemia is, therefore, an appealing strategy. Whilst erythropoietin levels may be elevated in CHF, they are often lower than expected when considering the haemoglobin concentration, indicating a relative deficiency. Similarly, iron metabolism is frequently disturbed, with many patients experiencing either an absolute or functional deficiency. Chronic iron deficiency may contribute to breathlessness and reduced exercise capacity, the hallmarks of symptomatic CHF. This supplement aims to increase awareness of anaemia in CHF and also to provide an overview of recent studies of erythropoiesis-stimulating agents (ESAs) and of intrav
You need to be a member to print this page.
Find out more about our membership benefits
You need to be a member to download PDF's.
Find out more about our membership benefits